https://www.selleckchem.com/GSK-3.html
e continually promoted to facilitate access to intravenous thrombolysis for patients with acute ischemic stroke.Measurement of a single marker of coagulation may not provide a complete picture of hemostasis activation and fibrinolysis in patients with chronic cardiovascular diseases. We assessed retrospective orders of a panel which included prothrombin fragment 1.2 (PF1.2), thrombin antithrombin complexes, fibrin monomers, and D-dimers in patients with heart assist devices, cardiomyopathies, atrial fibrillation and intracardiac thrombosis (based
Like
Comment
Share
